Sign inJoin waitlistJoin the waitlist

Beryl Manning-Geist

Physician · Emory University School of Medicine

Credentials: · · ·

History

Emory University School of Medicine
2025–Present

Gynecologic Oncology
Memorial Sloan Kettering Cancer Center
2021–2024
Obstetrics and Gynecology
Brigham and Women's Hospital
2016–2017
Emory University School of Medicine
2012–2016
Williams College
2008–2012

Research

MAPK Pathway Genetic Alterations Are Associated with Prolonged Overall Survival in Low-Grade Serous Ovarian Carcinoma
Clinical Cancer Research · 2022 · Co-first of 17 authors · 77 citations
Microsatellite Instability-High Endometrial Cancers with MLH1 Promoter Hypermethylation Have Distinct Molecular and Clinical Profiles
Clinical Cancer Research · 2022 · Co-first of 23 authors · 64 citations
Patient-reported benefit from proposed interventions to reduce financial toxicity during cancer treatment
Supportive Care in Cancer · 2022 · 50 citations

NA
Nadeem Abu-Rustum
17 papers
CA
Carol Aghajanian
13 papers
RG
Rachel Grisham
13 papers
Dennis Chi
12 papers
SG
Sushmita Gordhandas
12 papers · 12 as a fellow
ML
Mario Leitao
11 papers
Oliver Zivanovic
11 papers
YS
Yukio Sonoda
11 papers
KL
Kara Long
10 papers
Marcela del Carmen
9 papers · 9 as a resident
RO
Roisin O'Cearbhaill
9 papers
JM
Jennifer Mueller
8 papers

Clinical trials

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Site PI · Recruiting · Phase 3
Eli Lilly and Company
2025–2031
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Site PI · Recruiting · Phase 1, Phase 2
Novartis Pharmaceuticals
2019–2030